Florie Borel
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 10%
- RNA Interference and Gene Delivery
- CRISPR and Genetic Engineering
- Circular RNAs in diseases
Papers in
-
- RNA Interference and Gene Delivery 9
- Advanced biosensing and bioanalysis techniques 3
- RNA Research and Splicing 3
-
- MicroRNA in disease regulation 5
- Protease and Inhibitor Mechanisms 5
- Co-authors
- Pavlina Konstantinova (7 shared papers)Peter L. M. Jansen (3 shared papers)Christian Mueller (14 shared papers)Mark A. Kay (2 shared papers)Harald Petry (6 shared papers)Gwladys Gernoux (5 shared papers)Allerdien Visser (1 shared paper)Ruiqi Han (1 shared paper)
- Journals
- Molecular Therapy (5 papers)Proceedings of the National Academy of Sciences (2 papers)Human Gene Therapy (1 paper)Journal of Hepatology (1 paper)BMC Biotechnology (1 paper)
- Partner nations
- United StatesNetherlandsFrance
In The Last Decade
Florie Borel
23 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 84
- Cancer Research 339
- Molecular Biology 695
- Genetics 98
- Genetics 232
- Hepatology 49
Countries citing papers authored by Florie Borel
This map shows the geographic impact of Florie Borel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florie Borel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florie Borel more than expected).
Fields of papers citing papers by Florie Borel
This network shows the impact of papers produced by Florie Borel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florie Borel. The network helps show where Florie Borel may publish in the future.
Co-authors
The 25 scholars most cited alongside Florie Borel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 196 | |
| 2 | 2011 | 134 | |
| 3 | 2013 | 111 | |
| 4 | 2008 | 87 | |
| 5 | 2015 | 87 | |
| 6 | 2017 | 82 | |
| 7 | 2018 | 64 | |
| 8 | 2018 | 55 | |
| 9 | 2017 | 55 | |
| 10 | In vivo knock-down of multidrug resistance transporters ABCC1 and ABCC2 by AAV-delivered shRNAs and by artificial miRNAs. | 2011 | 42 |
| 11 | 2011 | 27 | |
| 12 | 2012 | 22 | |
| 13 | 2017 | 20 | |
| 14 | 2021 | 20 | |
| 15 | 2012 | 19 | |
| 16 | 2013 | 10 | |
| 17 | 2022 | 9 | |
| 18 | 2019 | 7 | |
| 19 | 2019 | 3 | |
| 20 | 2017 | 2 |
About Florie Borel
Florie Borel is a scholar working on Molecular Biology, Cancer Research, Oncology, Genetics and Immunology, having authored 23 papers that have together received 1.1k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (9 papers), MicroRNA in disease regulation (5 papers), Virus-based gene therapy research (5 papers), Protease and Inhibitor Mechanisms (5 papers), Advanced biosensing and bioanalysis techniques (3 papers), RNA Research and Splicing (3 papers), Neurogenetic and Muscular Disorders Research (3 papers) and Peptidase Inhibition and Analysis (3 papers). The work is most often cited by research in Cancer Research (339 citations), Molecular Biology (695 citations), Genetics (98 citations), Genetics (232 citations) and Hepatology (49 citations). Florie Borel has collaborated with scholars based in United States, Netherlands and France. Frequent co-authors include Pavlina Konstantinova, Peter L. M. Jansen, Christian Mueller, Mark A. Kay, Harald Petry, Gwladys Gernoux, Allerdien Visser, Ruiqi Han, Sander J. H. van Deventer and Robert H. Brown. Their work appears in journals such as Molecular Therapy, Proceedings of the National Academy of Sciences, Human Gene Therapy, Journal of Hepatology and BMC Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.